Zonisamide Capsules recalled over manufacturing violations
- Recall date
- April 22, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wockhardt Usa Inc. recalls Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai…
- Recall number
- D-1274-2015
- FDA classification
- Class II
- Brand / firm
- Wockhardt Usa Inc.
- Sold / distributed
- U.S. Nationwide including Puerto Rico.
Why it was recalled
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Zonisamide Capsules, 25 mg Capsules, Packaged in 100 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-0945-01.
Get recall alerts
Free email alert whenever Wockhardt Usa Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wockhardt Usa Inc.